Novo Nordisk plans to start late-stage trials for experimental obesity drug amycretin

reuters.com/business/healthcare-pharmaceuticals/novo-nordisk-plans-start-late-stage-trials-experimental-obesity-drug-amycretin-2025-06-12

This story appeared on reuters.com, 2025-06-12 17:22:37.565000.
The Entire Business World on a Single Page. Free to Use →